Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized, Blinded, Double Dummy, Multi-center, Placebo Controlled, 3 Period, Crossover Study to Assess the Effect of QVA149 (110/50 µg o.d.) on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control.
indacaterol, glycopyrrolate
CQVA149A2305
NCT01294787
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
 
June 2016

Powered by ideaPoint, Inc.